Overview

Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunt

Status:
Terminated

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

Visual assessment of diagnostic PET/CT (positron emission tomography/computed tomography) images obtained after a single intravenous injection of BAY86-4367 in patients with cancer

Phase:

Phase 1

Details

Lead Sponsor:

Bayer

Treatments:

Bombesin